Your Health, We Care

Home >Drug List>Talazoparib>Indications of Talazoparib

Talazoparib(LuciTala)

Release date: 2026-10-21 13:51:53     Recommended: 3

As monotherapy for adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), HER2-negative locally advanced or metastatic breast cancer; in combination with enzalutamide